SZodixStudyAcademic Library
DashboardShelvesOpen accessMy libraryInboxNotesWriteLearnAlerts
More
Ask your libraryNotificationsQuick citeReview
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
7 references·16 citing·39 second hop
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning (2013)Effects of psilocybin on hippocampal neur…Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot Study of Psilocybin Tre…Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder (2006)Safety, Tolerability, and Eff…Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study (2004)Acute psychological and physi…The pharmacology of psilocybin (2002)The pharmacology of psilocybin5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride (1999)5-HT Modulation of Dopamine R…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim (1958)Psilocybin, ein psychotroper …Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review (2023)Treatment of Posttraumatic St…Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity (2022)Biochemical Mechanisms Underl…Psychedelics and Other Psychoplastogens for Treating Mental Illness (2021)Psychedelics and Other Psycho…Models of psychedelic drug action: modulation of cortical-subcortical circuits (2021)Models of psychedelic drug ac…Reviewing the Potential of Psychedelics for the Treatment of PTSD (2020)Reviewing the Potential of Ps…Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Psychedelics in Psychiatry: N…Pivotal mental states (2020)Pivotal mental statesLow Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers (2020)Low Doses of LSD Acutely Incr…Long-term effects of psychedelic drugs: A systematic review (2020)Long-term effects of psychede…A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms (2019)A single inhalation of vapor …Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution (2018)Sub-acute and long-term effec…Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression (2018)Effects of N,N-Dimethyltrypta…Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT) (2018)Dark Classics in Chemical Neu…Clinical applications of hallucinogens: A review. (2016)Clinical applications of hall…Classic hallucinogens in the treatment of addictions (2015)Classic hallucinogens in the …Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles (2014)Classical hallucinogens as an…Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist in healthy volunteers (2002)Psilocybin – Summary of knowledge and new perspectives (2013)Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)The Yale-Brown Obsessive Compulsive Scale (1989)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)SCL-90: an outpatient psychiatric rating scale--preliminary report. (1973)Das State-Trait-Angstinventar (STAI) : theoretische Grundlagen und Handanweisung (1981)Serotonin research: contributions to understanding psychoses (2008)Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)Predicting Responses to Psychedelics: A Prospective Study (2018)An Inventory for Measuring Depression (1961)The Brief Psychiatric Rating Scale (1962)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies (2020)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects (2021)Default Mode Network Modulation by Psychedelics: A Systematic Review (2022)Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials (2022)The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)A non-hallucinogenic LSD analog with therapeutic potential for mood disorders (2023)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act (2018)Emotions and brain function are altered up to one month after a single high dose of psilocybin (2020)Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression (2017)The Therapeutic Potential of Psilocybin (2021)
this work references cited by second hop

References

  • 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2006Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder789 cited
  • 2002The pharmacology of psilocybin463 cited
  • 2004Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study451 cited
  • 19995-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride304 cited
  • 1958Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim280 cited

Cited by

  • 2020Reviewing the Potential of Psychedelics for the Treatment of PTSD260 cited
  • 2020Long-term effects of psychedelic drugs: A systematic review258 cited
  • 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms231 cited
  • 2015Classic hallucinogens in the treatment of addictions226 cited
  • 2023Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review215 cited
  • 2018Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution211 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2016
Clinical applications of hallucinogens: A review.
201 cited
  • 2021Models of psychedelic drug action: modulation of cortical-subcortical circuits199 cited
  • 2019A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms197 cited
  • 2018Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression171 cited
  • 2021Psychedelics and Other Psychoplastogens for Treating Mental Illness166 cited
  • 2020Pivotal mental states151 cited
  • 2022Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity131 cited
  • 2020Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers130 cited
  • 2014Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles121 cited
  • 2018Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)117 cited